Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:06 2024-05-01 pm EDT After market 05:13:59 pm
27.18 USD +6.09% Intraday chart for Pfizer, Inc. 27.07 -0.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
US Equity Markets Close Mixed Wednesday After Fed Holds Rates Steady MT
Sector Update: Health Care Stocks Rise Late Afternoon MT
PFIZER INC : Jefferies gives a Buy rating ZD
Trending : Pfizer 1Q Earnings Top Estimates; Raises FY24 View DJ
Sector Update: Health Care Stocks Advance Wednesday Afternoon MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET DJ
Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits MT
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET DJ
Pfizer lifts profit view on cost cuts RE
Pfizer Plans to Launch Online Platform for COVID-19, Migraine Drugs MT
Transcript : Pfizer Inc., Q1 2024 Earnings Call, May 01, 2024
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET DJ
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday MT
PFIZER INC : UBS remains Neutral ZD
Pfizer Lifts Full-Year 2024 Earnings Outlook Following First-Quarter Beat MT
PFIZER INC : JP Morgan remains Neutral ZD
Pfizer Earnings Top Views; Boosts Full-Year Guidance DJ
Pfizer Q1 Adjusted Earnings, Revenue Decline; 2024 Adjusted Earnings Outlook Lifted -- Shares Gain Pre-Bell MT
Fed Outlook Blunts Wall Street Pre-Bell; Asia, Europe Off MT
Stocks Mostly Down Pre-Bell Ahead of Fed Policy Decision; Asia Churns, Europe Falls MT
Avacta picks Christina Coughlin to replace long-serving CEO AN
PFIZER CEO: RECORDED FAVORABLE ADJUSTMENT TO REVENUES OF $771 M… RE
(PFE) PFIZER Expects Fiscal Year 2024 Revenue Range $58.5B - $61.5B MT
(PFE) PFIZER Expects Fiscal Year 2024 EPS Range $2.15 - $2.35 MT
Earnings Flash (PFE) PFIZER Posts Q1 Revenue $14.88B, vs. Street Est of $13.92B MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
25.62 USD
Average target price
31.62 USD
Spread / Average Target
+23.42%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Morgan Stanley Adjusts Pfizer's Price Target to $60 From $50, Maintains Equalweight Rating